EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 275 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $267,000 | -35.7% | 4,245 | -5.0% | 0.03% | -53.2% |
Q1 2021 | $415,000 | -5.3% | 4,467 | -8.5% | 0.06% | -20.5% |
Q4 2020 | $438,000 | -16.3% | 4,884 | -3.4% | 0.08% | -29.1% |
Q3 2020 | $523,000 | -19.0% | 5,058 | -4.2% | 0.11% | -20.9% |
Q2 2020 | $646,000 | +33.5% | 5,277 | -11.4% | 0.14% | +8.6% |
Q1 2020 | $484,000 | +24.1% | 5,959 | -4.1% | 0.13% | +39.1% |
Q4 2019 | $390,000 | +12.4% | 6,213 | -6.3% | 0.09% | -60.2% |
Q3 2019 | $347,000 | +13.8% | 6,629 | +5.1% | 0.23% | -1.7% |
Q2 2019 | $305,000 | -37.6% | 6,309 | -23.6% | 0.24% | -49.8% |
Q4 2018 | $489,000 | -14.7% | 8,255 | -5.2% | 0.47% | -3.1% |
Q3 2018 | $573,000 | +35.5% | 8,708 | +3.9% | 0.48% | +26.8% |
Q2 2018 | $423,000 | -18.2% | 8,382 | -14.7% | 0.38% | -20.3% |
Q1 2018 | $517,000 | +9.3% | 9,823 | -3.5% | 0.48% | +11.4% |
Q4 2017 | $473,000 | -5.0% | 10,183 | -17.4% | 0.43% | -4.9% |
Q3 2017 | $498,000 | +19.7% | 12,321 | -0.5% | 0.45% | +68.9% |
Q2 2017 | $416,000 | – | 12,386 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
AtonRa Partners | 11,505 | $472,000 | 0.26% |